Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
30/05/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:OCEAW | Ocean Biomedical Inc |
14/05/2024 | 21:10 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:OCEAW | Ocean Biomedical Inc |
25/05/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Addition to the Russell 2000® Index | NASDAQ:OCEAW | Ocean Biomedical Inc |
23/05/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Award for Novel Cancer Immunotherapy Treatment, Granted for Prostate Cancer, Colon Cancer, Ovarian Cancer, Kidney Cancer, Breast Cancer, Glioblastoma, Melanoma, and Lung Cancer. | NASDAQ:OCEAW | Ocean Biomedical Inc |
16/05/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical, Inc. Enters into a $25 Million Convertible Note Facility | NASDAQ:OCEAW | Ocean Biomedical Inc |
01/05/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Announces 70% Increase in Price Target by EF Hutton from $10 to $17 on New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody | NASDAQ:OCEAW | Ocean Biomedical Inc |
27/04/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Announces New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody | NASDAQ:OCEAW | Ocean Biomedical Inc |
25/04/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) on World Malaria Day Announces Sharing of New Malaria Vaccine Paradigm at PATH Malaria Research Retreat in Washington, DC, by Scientific Co-founder Dr. Jonathan Kurtis | NASDAQ:OCEAW | Ocean Biomedical Inc |
20/04/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Breakthrough Pulmonary Fibrosis Treatments Issued to Scientific Co-founder Dr. Jack A. Elias. | NASDAQ:OCEAW | Ocean Biomedical Inc |
17/04/2023 | 14:01 | GlobeNewswire Inc. | $134 Million in Financial Backing for Innovative Research and IND Fillings Announced by Ocean Biomedical (NASDAQ: OCEA); Provides Latest Updates on Advancement of Platform, Novel Discoveries in Malaria, Pulmonary Fibrosis and Oncology | NASDAQ:OCEAW | Ocean Biomedical Inc |
13/04/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Developing “Whole New Class” of Malaria Therapeutics Issued to Scientific Co-founder Dr. Jonathan Kurtis | NASDAQ:OCEAW | Ocean Biomedical Inc |
06/04/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Will Target Pulmonary Fibrosis Discoveries as Novel Treatments of Hermansky-Pudlak Syndrome | NASDAQ:OCEAW | Ocean Biomedical Inc |
21/03/2023 | 13:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Details Novel Malaria Therapeutic Discoveries at the NIH Laboratory of Malaria Vaccinology and Immunology on PfGARP’s Potential as a Highly Effective Vaccine Target and Therapeutic Candidate to Treat Malaria | NASDAQ:OCEAW | Ocean Biomedical Inc |
16/03/2023 | 13:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by Fundamental Research Corp. with a “Buy” Recommendation | NASDAQ:OCEAW | Ocean Biomedical Inc |
14/03/2023 | 13:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by EF Hutton with a “Buy” Recommendation | NASDAQ:OCEAW | Ocean Biomedical Inc |
09/03/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Shares Detailed Research Data on Anti-Tumor Pathway Discoveries and Their Potential for Treatment of Non-Small Cell Lung Cancer, Metastatic Melanoma, and Glioblastoma by Scientific Co-founder | NASDAQ:OCEAW | Ocean Biomedical Inc |
28/02/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Award of New Patent to Scientific Co-Founder Dr. Jake Kurtis for Novel Malaria Vaccine Target | NASDAQ:OCEAW | Ocean Biomedical Inc |
23/02/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical (NASDAQ: OCEA) Celebrates Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90% | NASDAQ:OCEAW | Ocean Biomedical Inc |
16/02/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical to Ring The Nasdaq Stock Market Opening Bell | NASDAQ:OCEAW | Ocean Biomedical Inc |
15/02/2023 | 14:01 | GlobeNewswire Inc. | Ocean Biomedical Debuts as Publicly Traded Company Focused on Accelerating the Commercialization of Innovative Assets from Research Universities and Medical Centers | NASDAQ:OCEAW | Ocean Biomedical Inc |
09/02/2023 | 15:15 | GlobeNewswire Inc. | Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Award of New Patents for Novel Monospecific and Bispecific Antibodies that Suppress Multiple Cancer Types | NASDAQ:OCEAW | Ocean Biomedical Inc |
30/01/2023 | 15:15 | GlobeNewswire Inc. | Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other Cancers | NASDAQ:OCEAW | Ocean Biomedical Inc |
24/01/2023 | 15:15 | GlobeNewswire Inc. | Ocean Biomedical Provides Corporate Update and Company Summary | NASDAQ:OCEAW | Ocean Biomedical Inc |
05/10/2022 | 13:45 | GlobeNewswire Inc. | Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce Execution of a Second up to $40 Million Backstop Agreement, for a Total of up to $80 Million | NASDAQ:OCEAW | Ocean Biomedical Inc |
31/08/2022 | 13:47 | GlobeNewswire Inc. | Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ | NASDAQ:OCEAW | Ocean Biomedical Inc |